Survival of Patients <= 50 Years of Age After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F14%3A00077662" target="_blank" >RIV/00216224:14110/14:00077662 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00159816:_____/14:00061123 RIV/00216208:11130/14:10292908 RIV/00064203:_____/14:10292908

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.cjca.2014.03.041" target="_blank" >http://dx.doi.org/10.1016/j.cjca.2014.03.041</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.cjca.2014.03.041" target="_blank" >10.1016/j.cjca.2014.03.041</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Survival of Patients <= 50 Years of Age After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Popis výsledku v původním jazyce

Background: The long-term efficacy and safety of alcohol septal ablation (ASA) has recently been demonstrated. However, there is still debate about the outcome of younger patients who should be treated using myectomy, according to American College of Cardiology Foundation/American Heart Association guidelines. The aim of this study was to evaluate the long-term outcome of patients &lt;= 50 years of age after ASA for hypertrophic obstructive cardiomyopathy (HOCM). Methods: We retrospectively evaluated consecutive, highly symptomatic patients aged &lt;= 50 years with HOCM who underwent ASA. Results: Institutional databases of 3 cardiovascular centres identified 290 patients with HOCM who underwent ASA; 75 (26%) of them were aged &lt;= 50 years at the time of their first ASA. Median duration of follow-up was 5.1 years (range, 0.1-15.4 years). Four patients (5%) died during the study period (438 patient-years; the annual mortality rate was 0.91%; 95% confidence interval [CI], 0.25-2.

Název v anglickém jazyce

Survival of Patients <= 50 Years of Age After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Popis výsledku anglicky

Background: The long-term efficacy and safety of alcohol septal ablation (ASA) has recently been demonstrated. However, there is still debate about the outcome of younger patients who should be treated using myectomy, according to American College of Cardiology Foundation/American Heart Association guidelines. The aim of this study was to evaluate the long-term outcome of patients &lt;= 50 years of age after ASA for hypertrophic obstructive cardiomyopathy (HOCM). Methods: We retrospectively evaluated consecutive, highly symptomatic patients aged &lt;= 50 years with HOCM who underwent ASA. Results: Institutional databases of 3 cardiovascular centres identified 290 patients with HOCM who underwent ASA; 75 (26%) of them were aged &lt;= 50 years at the time of their first ASA. Median duration of follow-up was 5.1 years (range, 0.1-15.4 years). Four patients (5%) died during the study period (438 patient-years; the annual mortality rate was 0.91%; 95% confidence interval [CI], 0.25-2.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Canadian Journal of Cardiology

ISSN

0828-282X

e-ISSN

—

Svazek periodika

30

Číslo periodika v rámci svazku

6

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

5

Strana od-do

634-638

Kód UT WoS článku

000339250300008

EID výsledku v databázi Scopus

—